Dysnatremia, its correction, and mortality in patients undergoing continuous renal replacement therapy: A prospective observational study

BMC Nephrology

Volumn 17, Issue 1, 2016, Pages

  Han, Seung Seok ^a   Bae, Eunjin ^a   Kim, Dong Ki ^a   Kim, Yon Su ^a   Han, Jin Suk ^a   Joo, Kwon Wook ^a  

^a Seoul National University   (South Korea)

Author keywords

Continuous renal replacement therapy; Dysnatremia; Hypernatremia; Hyponatremia; Mortality

Indexed keywords

SODIUM;

ADULT; APACHE; ARTICLE; CAUSE OF DEATH; CHARLSON COMORBIDITY INDEX; COHORT ANALYSIS; CONTINUOUS RENAL REPLACEMENT THERAPY; CONTROLLED STUDY; DISEASE SEVERITY; DYSNATREMIA; ELECTROLYTE DISTURBANCE; FEMALE; HUMAN; HYPERNATREMIA; HYPONATREMIA; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; SURVIVAL RATE; ACUTE KIDNEY INJURY; AGED; BLOOD; MIDDLE AGED; RENAL REPLACEMENT THERAPY; SEVERITY OF ILLNESS INDEX;

ACUTE KIDNEY INJURY; ADULT; AGED; FEMALE; HUMANS; HYPERNATREMIA; HYPONATREMIA; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RENAL REPLACEMENT THERAPY; SEVERITY OF ILLNESS INDEX; SODIUM;

EID: 84956582040     PISSN: None     EISSN: 14712369     Source Type: Journal    
DOI: 10.1186/s12882-015-0215-1     Document Type: Article

References (24)

1. Hoorn EJ, Zietse R. Hyponatremia and mortality: moving beyond associations. Am J Kidney Dis. 2013;62(1):139-49.
2. Lindner G, Funk GC, Schwarz C, Kneidinger N, Kaider A, Schneeweiss B, et al. Hypernatremia in the critically ill is an independent risk factor for mortality. Am J Kidney Dis. 2007;50(6):952-7.
3. Aranyi Z, Kovacs T, Szirmai I, Vastagh I. Reversible nerve conduction slowing in hyponatremia. J Neurol. 2004;251(12):1532-3.
4. Kozeny GA, Murdock DK, Euler DE, Hano JE, Scanlon PJ, Bansal VK, et al. In vivo effects of acute changes in osmolality and sodium concentration on myocardial contractility. Am Heart J. 1985;109(2):290-6.
5. Mohammed AA, van Kimmenade RR, Richards M, Bayes-Genis A, Pinto Y, Moore SA, et al. Hyponatremia, natriuretic peptides, and outcomes in acutely decompensated heart failure: results from the International Collaborative of NT-proBNP Study. Circ Heart Fail. 2010;3(3):354-61.
6. Chawla A, Sterns RH, Nigwekar SU, Cappuccio JD. Mortality and serum sodium: do patients die from or with hyponatremia? Clin J Am Soc Nephrol. 2011;6(5):960-5.
7. Dixon MB, Lien YH. Tolvaptan and its potential in the treatment of hyponatremia. Ther Clin Risk Manag. 2008;4(6):1149-55.
8. Hoste EA, Schurgers M. Epidemiology of acute kidney injury: how big is the problem? Crit Care Med. 2008;36(4 Suppl):S146-51.
9. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373-83.
10. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med. 1985;13(10):818-29.
11. Katz MA. Hyperglycemia-induced hyponatremia - calculation of expected serum sodium depression. N Engl J Med. 1973;289(16):843-4.
12. Yessayan L, Yee J, Frinak S, Szamosfalvi B. Treatment of severe hyponatremia in patients with kidney failure: role of continuous venovenous hemofiltration with low-sodium replacement fluid. Am J Kidney Dis. 2014;64(2):305-10.
13. Huang C, Zhang P, Du R, Li Y, Yu Y, Zhou M, et al. Treatment of acute hypernatremia in severely burned patients using continuous veno-venous hemofiltration with gradient sodium replacement fluid: a report of nine cases. Intensive Care Med. 2013;39(8):1495-6.
14. Bratusch-Marrain PR, DeFronzo RA. Impairment of insulin-mediated glucose metabolism by hyperosmolality in man. Diabetes. 1983;32(11):1028-34.
15. Knochel JP. Neuromuscular manifestations of electrolyte disorders. Am J Med. 1982;72(3):521-35.
16. Jensen AG, Wachmann CH, Poulsen KB, Espersen F, Scheibel J, Skinhoj P, et al. Risk factors for hospital-acquired Staphylococcus aureus bacteremia. Arch Intern Med. 1999;159(13):1437-44.
17. Thijssen S, Raimann JG, Usvyat LA, Levin NW, Kotanko P. The evils of intradialytic sodium loading. Contrib Nephrol. 2011;171:84-91.
18. Kovesdy CP. Significance of hypo- and hypernatremia in chronic kidney disease. Nephrol Dial Transplant. 2012;27(3):891-8.
19. Stewart IJ, Morrow BD, Tilley MA, Snow BD, Gisler C, Kramer KW, et al. Dysnatremias and survival in adult burn patients: a retrospective analysis. Am J Nephrol. 2013;37(1):59-64.
20. Kovesdy CP, Lott EH, Lu JL, Malakauskas SM, Ma JZ, Molnar MZ, et al. Hyponatremia, hypernatremia, and mortality in patients with chronic kidney disease with and without congestive heart failure. Circulation. 2012;125(5):677-84.
21. Funk GC, Lindner G, Druml W, Metnitz B, Schwarz C, Bauer P, et al. Incidence and prognosis of dysnatremias present on ICU admission. Intensive Care Med. 2010;36(2):304-11.
22. Greenberg A, Verbalis JG, Amin AN, Burst VR, Chiodo 3rd JA, Chiong JR, et al. Current treatment practice and outcomes. Report of the hyponatremia registry. Kidney Int. 2015;88(1):167-77.
23. Penne EL, Thijssen S, Raimann JG, Levin NW, Kotanko P. Correction of serum sodium for glucose concentration in hemodialysis patients with poor glucose control. Diabetes Care. 2010;33(7):e91.
24. Hillier TA, Abbott RD, Barrett EJ. Hyponatremia: evaluating the correction factor for hyperglycemia. Am J Med. 1999;106(4):399-403.